XML 32 R21.htm IDEA: XBRL DOCUMENT v3.19.2
Revenue from Contracts with Customers (Tables)
6 Months Ended
Jun. 30, 2019
Revenue from Contracts with Customers  
Summary of product revenue provision and allowance

    

    

Trade

Rebates and

Product

Allowances and

Incentives (1)

Returns (2)

Chargebacks (3)

Balance at December 31, 2018

$

129,318

$

15,465

$

14,841

Provision related to current period sales

128,509

9,150

31,988

Changes in estimate related to prior period sales

(3,017)

Credits/payments made

(119,659)

(1,502)

(32,673)

Balance at June 30, 2019

$

135,151

$

23,113

$

14,156

(1)

Rebates and incentives includes managed care rebates, government rebates, co-pay program incentives, and sales incentives and allowances. Provisions for rebates and discounts are deducted from gross revenues at the time revenues are recognized and are included in accrued rebates, returns and discounts in the Company’s Condensed Consolidated Balance Sheets.

(2)

Provisions for product returns are deducted from gross revenues at the time revenues are recognized and are included in accrued rebates, returns and discounts in the Company’s Condensed Consolidated Balance Sheets.

(3)

Trade allowances and chargebacks include fees for distribution service fees, prompt pay discounts, and chargebacks. Trade allowances and chargebacks are deducted from gross revenue at the time revenues are recognized and are recorded as a reduction to accounts receivable in the Company’s Condensed Consolidated Balance Sheets.

Schedule of disaggregation of revenue

Three months ended June 30, 

Six months ended June 30, 

2019

2018

2019

2018

Xtampza ER

$

26,018

    

$

18,116

$

51,152

$

33,911

Nucynta Products

 

49,022

 

54,945

 

98,404

 

102,899

Total product revenues, net

$

75,040

$

73,061

$

149,556

$

136,810